Molecular characteristics of repotrectinib that enable potent inhibition of TRK fusion proteins and broad mutant selectivity Meeting Abstract


Authors: Drilon, A.; Zhai, D.; Rogers, E.; Deng, W.; Chen, X.; Sprengeler, P.; Reich, S. H.; Murray, B. W.
Abstract Title: Molecular characteristics of repotrectinib that enable potent inhibition of TRK fusion proteins and broad mutant selectivity
Meeting Title: 112th Annual Meeting of the American Association for Cancer Research (AACR)
Journal Title: Cancer Research
Volume: 81
Issue: 13 Suppl.
Meeting Dates: 2021 Apr 10-15/May 17-21
Meeting Location: Philadelphia, PA
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2021-07-01
Language: English
ACCESSION: WOS:000680263503451
PROVIDER: wos
DOI: 10.1158/1538-7445.AM2021-1119
Notes: Meeting Abstract: 1119 -- Due to Covid 19 pandemic, the conference was held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon